| BRSV-MoreThan Just Four Letters On A Vaccination 
                      BottleBovine respiratory syncytial virus (BRSV) has been recognized 
                      as a pathogen in cattle since 1970. The presence of this 
                      virus in cattle herds is recognized world wide. In the United 
                      States antibody prevalence 
                      has been reported to 65% to 81% in the cattle population. Aerosolized secretions absorbed through the respiratory 
                      tract is the source of transmission from infected cattle 
                      into susceptible cattle. While bovine cell lines can be 
                      persistently infected, there have been no chronic carrier 
                      cattle demonstrated. Latent infections may occur in calves 
                      infected at birth and may provide an explanation for sudden 
                      outbreaks in calves raised in the isolation of individual 
                      calf hutches. Cattle most susceptible are beef calves six weeks to 13 
                      months of age and dairy calves two weeks to nine months. 
                      In younger calves mortality rates are increased by secondary 
                      bacterial infections resulting in severe exudative, fibrinous, 
                      or suppurativebronchopneumonia. Infections with BRSV have 
                      been implicated as the initiating cause of shipping fever 
                      and other respiratory disease complexes. Outbreaks of BRSV infection infrequently follow stressful 
                      weather changes. The morbidity of these infections usually 
                      ranges from 0% to 20%. By itself, BRSV can cause acute respiratory 
                      distress. Gross necropsy lesions are severe pulmonary edema 
                      and interstitial emphysema. There are often consolidated 
                      areas in the cranioventral lung lobes accompanied by severe 
                      emphysema and edema of the entire lung but primarily of 
                      the caudal lobes. Diagnosing BRSV infections starts with recognizing the 
                      clinical signs. Infections tend to be acute with nasal and 
                      ocular discharge, pyrexia, cough, progressive dyspnea, and 
                      occasionally subcutaneous emphysema. Laboratory diagnosis can be a challenge and diagnosis should 
                      not be made on any one test. Because the virus is so labile, 
                      virus isolation is rarely successful from the tissue of 
                      a post-mortem animal. The best sample for virus isolation 
                      is a tracheal wash or lung lavage.Nasopharyngeal swabs can 
                      also be used with good success. The IFA test is one of the 
                      most rapid, reliable, and sensitive tests currently available 
                      for the diagnosis of BRSV. The best samples for IFA are 
                      the same as for virus isolation. Other tests include immunohisto-chemistiy, 
                      virus neutralization tests, enzyme immunoassays for antibody 
                      detection,enzymeimmunoassays for antigen detection, nucleic 
                      acid detection tests and histopathology. Many of these tests 
                      are not used with very good success but many hold some promise 
                      for the future. Treatment of BRSV infections consists of a three step regimen. 
                      The first step is supportive therapy. Supportive therapy 
                      consists of keeping the affected animal well hydrated, maintaining 
                      proper electrolyte balance and providing a clean, well ventilated 
                      environment. The second step is to treat affected animals 
                      with antimicrobials to combat any secondary pathogens that 
                      may invade the already compromised lungs. The third step 
                      is the use of anti-inflammatory   drugs.   Because   of  
                      theimmunosuppression of corticosteriods these drugs are 
                      not recommended for use in the treatment of bovine respiratory 
                      disease. Non-steroidal anti-inflammatory drugs (NSAID) are 
                      the drugs of choice. Currently aspirin is the only NSAID 
                      that is approved for use in food animals. Prevention is the key to dealing with BRSV infections. 
                      Good husbandry and well ventilated housing is mandatory 
                      for the prevention of all respiratory diseases. Vaccination 
                      is another tool available to prevent BRSV infections. Both 
                      modified live vaccines and inactivated vaccines are available. 
                      Both types have pros and cons. Modified live vaccines  tend  
                      to  stimulate  stronger neutralizing antibodies responses. 
                      Both modified live   inactivated   vaccines   stimulate   
                      non-neutralizing antibody and prime T cells in calves. The presence of maternal antibodies in young calves can 
                      impede the immune response following vaccination with modified 
                      live vaccines. For this reason timing is crucial in the 
                      vaccination regiment. Beef calves should be vaccinated twice 
                      before weaning in order for them to be protected when they 
                      enter the feed lot. Vaccinating dairy calves should be done 
                      with inactivated vaccines or with modified live vaccines 
                      after the maternal antibodies have declined. Maternal antibodies 
                      have usually declined to undetectable levels by six months 
                      of age. - by Fred Froderman, Class of 1997 - edited by Greg Stevenson, DVM,PhD References: Ames,TrevorR., 
                      DVM: The Epidemiology of BRSV Infection. Veterinary Medicine. 
                      881-884;1993. Baker, John C.,DVM: Treating BRSV. Veterinary 
                      Medicine.900-902; 1993. Belknap,Ellen.,DVM: Recognizing 
                      the Clinical Signs of BRSV Infection. Veterinary Medicine.886-887; 
                      1993. Bryson, David G.,DVM: Necropsy Findings Associated with 
                      BRSV Pneumonia. Veterinary Medicine.888-893; 1993. Dubovi, Edward J.,DVM: Diagnosing BRSV Infection: A Laboratory 
                      Perspective. Veterinary Medicine.888-893; 1993. Kelling,ClaytonL.,DVM: Controlling BRSV Infection in Calves. 
                      Veterinary Medicine. 903-906; 1993. |